Future Science Group
Browse
Supplementary Table S1.pdf (90.51 kB)
Download file

Supplementary Tables – PD-L1 Expression as a Prognostic Marker in Patients treated with Chemotherapy for Metastatic Non-Small Cell Lung Cancer

Download (90.51 kB)
figure
posted on 2022-02-14, 16:57 authored by Figshare Future Science GroupFigshare Future Science Group, Rachel Woodford, Deborah Zhou, Sarah J Lord, Ian Marschner, Wendy A Cooper, Craig R Lewis, Thomas John, James Chih-Hsin Yang, Chee Khoon Lee

Supplementary Table S1. PD-L1 Expression as a Prognostic Marker in Patients treated with Chemotherapy for Metastatic Non-Small Cell Lung Cancer

Baseline patient characteristics and treatment received

History

Usage metrics

    Future OncologyFuture Oncology

    Categories

    Keywords

    biomarkerschemotherapymetastatic cancernon-small-cell lung cancerPD-L1prognostic markersCancer GeneticsChemotherapyMolecular TargetsSolid Tumours

    Licence

    CC BY-NC-ND 4.0

    Exports